Our studies using TCRVβ repertoire analysis techniques [45] as a viral integration independent clonal “bar-code” to identify the repertoire of CD4+ TCRαβ+ T cells in tumor-derived cell lines and with in vivo derived tumor samples revealed a characteristic of clonal dominance within an oligoclonal framework of tumor-capable CD4+ T cells. Here, CD4 is linked to neoplasm.